A.H. Tulusan

953 total citations
22 papers, 637 citations indexed

About

A.H. Tulusan is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, A.H. Tulusan has authored 22 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in A.H. Tulusan's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (6 papers) and Cancer Cells and Metastasis (4 papers). A.H. Tulusan is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (6 papers) and Cancer Cells and Metastasis (4 papers). A.H. Tulusan collaborates with scholars based in Germany and Austria. A.H. Tulusan's co-authors include Gϋnter von Minckwitz, Serban Dan Costa, Manfred Kaufmann, Jens‐Uwe Blohmer, W. Eiermann, Christian Jackisch, Luca Gianni, Philippe Beuzeboc, Roy E. Smith and Vicente Valero and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and The Oncologist.

In The Last Decade

A.H. Tulusan

17 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.H. Tulusan Germany 9 452 387 210 96 84 22 637
Günther Raab Germany 8 465 1.0× 394 1.0× 210 1.0× 87 0.9× 56 0.7× 10 605
Debbie Frye United States 8 373 0.8× 396 1.0× 126 0.6× 60 0.6× 44 0.5× 13 556
G. Raab Germany 7 483 1.1× 487 1.3× 178 0.8× 30 0.3× 67 0.8× 19 650
L Thill France 7 267 0.6× 308 0.8× 189 0.9× 52 0.5× 56 0.7× 9 546
Riccardo Giovanazzi Italy 11 320 0.7× 201 0.5× 204 1.0× 178 1.9× 132 1.6× 24 583
S. Peter Eggleton Germany 9 310 0.7× 418 1.1× 132 0.6× 82 0.9× 77 0.9× 21 618
J.L. Achard France 12 398 0.9× 304 0.8× 206 1.0× 106 1.1× 45 0.5× 31 630
Charles E. Leonard United States 11 392 0.9× 224 0.6× 163 0.8× 134 1.4× 99 1.2× 34 621
Lars-Gunnar Arnesson Sweden 7 470 1.0× 287 0.7× 311 1.5× 131 1.4× 57 0.7× 8 587
A. Romero Argentina 9 136 0.3× 437 1.1× 96 0.5× 51 0.5× 39 0.5× 13 525

Countries citing papers authored by A.H. Tulusan

Since Specialization
Citations

This map shows the geographic impact of A.H. Tulusan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.H. Tulusan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.H. Tulusan more than expected).

Fields of papers citing papers by A.H. Tulusan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.H. Tulusan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.H. Tulusan. The network helps show where A.H. Tulusan may publish in the future.

Co-authorship network of co-authors of A.H. Tulusan

This figure shows the co-authorship network connecting the top 25 collaborators of A.H. Tulusan. A scholar is included among the top collaborators of A.H. Tulusan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.H. Tulusan. A.H. Tulusan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schindlbeck, Christian, Udo Jeschke, Uwe Karsten, et al.. (2008). Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clinical & Experimental Metastasis. 25(3). 233–240. 29 indexed citations
3.
Kaufmann, Manfred, Gϋnter von Minckwitz, Roy E. Smith, et al.. (2003). International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations. Journal of Clinical Oncology. 21(13). 2600–2608. 265 indexed citations
4.
Buehner, Markus, et al.. (2003). Sentinel lymph node biopsy after neoadjuvant therapy in breast cancer. The Breast. 12. S34–S34.
5.
Berger, A., Cle mens Tempfer, Beda Hartmann, et al.. (2001). Sealing of Postoperative Axillary Leakage After Axillary Lymphadenectomy Using a Fibrin Glue Coated Collagen Patch: a Prospective Randomised Study. Breast Cancer Research and Treatment. 67(1). 9–14. 47 indexed citations
7.
Fietkau, Rainer, et al.. (1994). Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas.. PubMed. 170(1). 13–24. 6 indexed citations
8.
Köster, Anja, Alfred Leipold, Richard Sachse, et al.. (1991). Expression of oncogenes in human breast cancer specimens.. PubMed. 11(1). 193–201. 21 indexed citations
9.
Jager, Wilco de, et al.. (1991). Modifizierte Mammakarzinom-Nachsorge. Gyn�kologisch-geburtshilfliche Rundschau. 31(2). 296–299.
10.
Tulusan, A.H., et al.. (1990). [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].. PubMed. 11(6). 327–31. 1 indexed citations
11.
Jäger, W., et al.. (1990). Resection guided by antibodies (REGAJ): a diagnostic procedure during second-look operation in ovarian cancer patients.. PubMed. 10. 18–20. 10 indexed citations
12.
Tulusan, A.H., et al.. (1989). Antiemetische Therapie bei Cisplatin Chemotherapien. Gyn�kologisch-geburtshilfliche Rundschau. 29(2). 374–377.
13.
Adam, R., et al.. (1988). Das Lokalrezidiv beim Mammakarzinom. Geburtshilfe und Frauenheilkunde. 48(5). 322–325. 1 indexed citations
14.
Tulusan, A.H., et al.. (1988). Die Rolle der Mammographie bei der Diagnose von simultanen Zweitkarzinomen in der kontralateralen Brust. Geburtshilfe und Frauenheilkunde. 48(8). 579–583. 2 indexed citations
15.
Tulusan, A.H., et al.. (1985). A contribution to the natural history of breast cancer. Archives of Gynecology and Obstetrics. 237(2). 85–91. 18 indexed citations
16.
Tulusan, A.H. & S. Trotnow. (1983). Endometriotic ureteric obstruction after hysterectomy. Archives of Gynecology and Obstetrics. 234(2). 149–51. 1 indexed citations
17.
Egger, H., et al.. (1982). A contribution to the natural history of breast cancer. Archives of Gynecology and Obstetrics. 231(3). 199–208. 1 indexed citations
18.
Brunner, Peter, et al.. (1977). Die pulmonale Silikonembolie. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 373(1). 55–65. 3 indexed citations
19.
Hofmann, Kay, Peter Brunner, & A.H. Tulusan. (1976). Abbau �liger Substanzen in der Kaninchenlunge. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 369(4). 347–358. 2 indexed citations
20.
Brunner, Peter, et al.. (1975). [Proceedings: Activity of non-specific pulmonary esterase following artificial fat embolism. Histo- and ultrahistochemical studies].. PubMed. 59. 444–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026